Clinical Trials
Bharat Biotechs Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two...
Press Releases
Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine inthe Indian Market
Dr. Reddy’s Laboratories Ltd. announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1stMay, 2021,...
Packaging & Labelling
Envirotainer launches the Releye RLP – simpler than passive, even better than active
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, launched their latest innovation, the Releye® RLP, a temperature-controlled...
Press Releases
21st Edition Strategic Project & Portfolio Management for Pharma
The economic turmoil has taken a toll on pharma and biotech companies who have been confronted by stringent regulations and budget cuts in R&D....
News
Phesi calls for sponsors to rethink ‘primitive’ clinical trial approaches and adopt modal value guided design
Virtual clinical development specialists, Phesi Inc., are calling for clinical trials to be designed using industry modal values (data values that appear most often...
News
Prevention-focused model is important in Indian Healthcare Industry
India has actually always believed in a disease prevention model of healthcare -- the Ayurveda system, which relies heavily on keeping one’s body and...
News
WHO classifies India Covid strain as ‘variant of concern’
The B-1617 variant of coronavirus, first identified in India, has been classified as a “variant of concern” at the global level by the World...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read